Polyphor News

Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine Act
Beginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ
Special Studies in Cancer Patients: AME and Cardiac Safety
FierceBiotech Editor John Carroll will moderate an expert panel discussion exploring how c
Biomarkers and Translational Medicine in Early Phase Oncology Clinical Development (Part two of our three part series)
Increasingly, new technologies are making it possible to carefully identify sets of patien
Getting the most out of First-in-Human and Early Clinical Trials
In a follow-up to our webinar last month on first-in-human drug studies, FierceBiotech edi

Polyphor News

Most Popular Polyphor Story

October 31, 2008 — 8:49am ET | By Calisha Myers

Allergan is busy these days. Yesterday, the California biotech announced a deal with Spectrum Pharmaceuticals, which, among other things, gave Allergan exclusive rights to apaziquone for the Read more...

Latest Headlines